ChristianaCare Is First in Delaware to Offer CAR-T Therapy for Advanced Multiple Myeloma

ChristianaCare’s Helen F. Graham Cancer Center & Research Institute is the first in Delaware to offer a powerful new tool in the fight against multiple myeloma — a type of blood cancer that affects plasma cells in the bone marrow. That tool is a new chimeric antigen receptor (CAR) T-cell therapy, called CARVYKTI, which can […]

The post ChristianaCare Is First in Delaware to Offer CAR-T Therapy for Advanced Multiple Myeloma appeared first on ChristianaCare News.